Evidence map›Paper›PMID 40662036›Full record

ArticleCureus2025

Small Cell Type Poorly Differentiated Neuroendocrine Cancer of the Gallbladder.

Akansha, Madhumita Tripathi, Roli Purwar, Mridula Shukla, Manoj Pandey

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

AkanshaSurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Madhumita TripathiSurgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Roli PurwarSurgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Mridula ShuklaPathology, Dr. Lalpath Labs Pvt. Ltd, Varanasi, IND.
Manoj PandeySurgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumor (NET) is a rare gallbladder (GB) malignancy and is seldom seen in clinical practice. There is a scarcity of reported cases, or extensive studies, hence not much is known about the disease. We present here the case of a 62-year-old woman, presenting with jaundice as the only symptom. On subsequent investigations, it was diagnosed to be poorly differentiated neuroendocrine carcinoma (NEC) of the GB with invasion of adjoining organs and peritoneal metastasis and was managed with palliative chemotherapy. At present, the treatment of choice for GB NET is surgical resection, but it is possible in only very limited cases due to metastatic disease at the time of first presentation. Hence, in such cases, chemotherapy remains a feasible alternative.

Indexed as

gallbladderhepatobiliary cancerneuroendocrine cancerneuroendocrine tumor (net)small cell carcinoma

Identifiers

PMID40662036
PMCPMC12258609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.